Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-894-6 | CAS number: 29857-13-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1 889.1 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA factors in combination with recent scientific literature
- Overall assessment factor (AF):
- 8.4
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 15 868 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Key 90-day oral toxicity study available; no repeated dose inhalation toxicity study available.
- AF for dose response relationship:
- 1
- Justification:
- Different doses were tested in the various studies, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1.4
- Justification:
- The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is already applied in route-to-route extrapolation.
- AF for other interspecies differences:
- 1
- Justification:
- No toxicodynamic differences between species; see justification attached.
- AF for intraspecies differences:
- 2.4
- Justification:
- Refined assessment of population differences; see justification attached.
- AF for the quality of the whole database:
- 1
- Justification:
- Results were based on key Klimisch 1-2 studies (and possible supporting studies).
- AF for remaining uncertainties:
- 2.5
- Justification:
- For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 267.86 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA factors in combination with recent scientific literature
- Overall assessment factor (AF):
- 33.6
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 9 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Key 90-day oral toxicity study available; no repeated dose dermal toxicity study available.
- AF for dose response relationship:
- 1
- Justification:
- Different doses were tested in the various studies, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1.4
- Justification:
- The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- ECHA default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- No toxicodynamic differences between species; see justification attached.
- AF for intraspecies differences:
- 2.4
- Justification:
- Refined assessment of population differences; see justification attached.
- AF for the quality of the whole database:
- 1
- Justification:
- Results were based on key Klimisch 1-2 studies (and possible supporting studies).
- AF for remaining uncertainties:
- 2.5
- Justification:
- For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- no DNEL required: short term exposure controlled by conditions for long-term
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
- Humans do not have non-glandular stomach (forestomach).
- Gastric lesions only seen at 1 site in these animals, no other tissues are involved.
- There was a clear dose-response: it was observed at the highest and mid dose and not at the low dose, so there is a clear threshold.
- This high oral exposure volume is not applicable in humans; and humans do not have the same stomach anatomy (no forestomach in humans).
- Genotoxicity studies are negative (Ames, Micronucleus, Mammalian genotoxicity).
- It was only observed with gavage dosing; the gavage is giving a bolus dose, which is considered excessive.
Source information for DNELS:
The following source information was taken into account for DNEL calculation:
Subacute toxicity was tested with the registered substance in Wistar rats by oral gavage at 0 (propylene glycol), 100, 300 and 1000 mg /kg bw/day in a supporting 14-day dose range finding and at 0 (propylene glycol), 100, 300 and 1000 mg /kg bw/day in a key combined repeated dose/reproductive toxicity study (OECD No. 422). In summary, the test substance did not result in test item related mortality or adverse clinical signs. Test item related adverse effects were observed on body weight gain parameters and food consumption in High dose (600 mg/kg bw/day) males and moderate effects were observed on body weight and body weight gain in the gestation and lactation period for High dose females. It is most likely these effects were related to local gastric irritation. There were no adverse changes in animal behaviour, general physical condition or in the reactions to different type of stimuli or in clinical pathology in test item treated groups when compared to control. There was no test item effect on mortality or survival of the pups. Test item-related effects were observed in the liver (increased relative organ weights in Mid and High dose males and females) associated with centrilobular hepatocellular hypertrophy in the High dose. Hepatic changes were considered to be adaptive and non-adverse. Test item related effect was observed in the organ weight of the heart (decreased absolute and relative organ weight) of the High dose males (not in females) compared to controls. However, there were no histopathological findings which indicates any adversity. Histologically, test item-related changes were observed in the stomach in High and Mid dose animals with squamous hyperplasia, hyperkeratosis and ulcer of the non-glandular gastric mucosa observed at 300 and 600 mg/kg bw/day dose level in females and at 100, 300 and 600 mg/kg bw/day dose level in males, as test item-related adverse local changes. Sporadic cases of noisy respiration in a few animals ascribed to reflux or minor exposure to test item in the region of the upper respiratory tract. Also, centrilobular hepatocellular hypertrophy was observed at 600 mg/kg bw/day dose level as a non-adverse adaptive change (associated with liver weight increase). Minimal to mild multifocal eosinophilic droplets/globules were seen in the renal tubules in the High dose males and were considered as test item-related but non-adverse. The NOAEL for local toxicity of the parental generation was <100 mg/kg bw/day (based on local gastric histological effects in Low, Mid and High dose animals). The NOAEL for systemic toxicity of the parental generation was considered to be 300 mg/kg bw/day. (based on body weight, body weight gain and food consumption changes at 600 mg/kg bw/day, although these effects were probably secondary to local gastric irritation).
No test item related changes were noted in the reproductive parameters during mating and gestation, delivery and post-partum/lactation period until PPD 14. The litter size of control and treated groups were comparable. A slightly lower pup growth/weight at the High dose, while within the historic control range, may be related to maternal toxicity (gastric irritation/food intake); there is no indication of a direct adverse effect of the test item on pup development. Under the experimental conditions of this study and based on the results of thyroid hormone measurement, thyroid weights, nipple retention, anogenital distance and external reproductive organs analysis, histopathology and reproductive performance, there was no evidence for any endocrine effects. There was no test item effect on mortality or survival of the pups. The litter size of control and treated groups were comparable. A slightly lower pup growth/weight at the High dose, while within the historic control range, may be related to maternal toxicity (gastric irritation/food intake); there is no indication of a direct adverse effect of the test item on pup development. The NOAEL for reproductive effects of the parental generation was considered to be 600 mg/kg bw/day. The NOAEL for Pup development and survival was considered to be 600 mg/kg bw/day.
Repeated dose toxicity was further tested in various species, including rats, dogs, rabbits and monkeys. The NOAEL of 750 mg/kg bw/day obtained in the subchronic 90-day dietary toxicity study in rats with registered substance was confirmed to be consistent with data from category members in rats and the NOAEL of 1000 mg/kg bw of Docusate sodium in a 90-day dietary toxicity study. Other data from other species were tested with read-across substance and were of limited reliability and relevance and therefore not taken into account.
Based on the above information, the NOAEL of 300 mg/kg bw/day of the OECD 422 study is considered too conservative. The gross and histological changes in the non-glandular stomach (forestomach) are considered to be due to repeated irritation, and not relevant for humans as supported by following arguments.
In conclusion, the NOAEL of 300 mg/kg bw is rather a local NOAEL for rodents under the oral gavage conditions. As there is a NOAEL of 750-1000 mg/kg bw from the 90-day dietary toxicity study, DNEL derivation will not be based on the oral gavage study but on the dietary 90-day study with Docusate, waiting new data from the 90-day study with registered substance. A justification for calculation of DNELs is attached.
Only systemic long term exposure values for worker and general population were calculated, because no concrete values (like NOAEL, LOAEL etc) are available from acute or irritation studies. The study design of the test conducted assessing the acute and local toxicity does not allow in general the derivation of local or acute DNEL, as most of the tests were, for example, conducted as limit tests due to animal welfare. Therefore a qualitative risk assessment for irritation is performed.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 559.1 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA factors in combination with recent scientific literature.
- Overall assessment factor (AF):
- 14
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 7 826 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Key 28-55 -day (OECD 422) oral toxicity study available; no repeated dose inhalation toxicity study available.
- AF for dose response relationship:
- 1
- Justification:
- Different doses were tested in the various studies, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1.4
- Justification:
- The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Allometric scaling is already applied in route-to-route extrapolation.
- AF for other interspecies differences:
- 1
- Justification:
- No toxicodynamic differences between species; see justification attached.
- AF for intraspecies differences:
- 4
- Justification:
- Refined assessment of population differences; see justification attached.
- AF for the quality of the whole database:
- 1
- Justification:
- Results were based on key Klimisch 1-2 studies (and possible supporting studies).
- AF for remaining uncertainties:
- 2.5
- Justification:
- For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 160.71 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA factors in combination with recent scientific literature
- Overall assessment factor (AF):
- 56
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 9 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Key 28-55 -day (OECD 422) oral toxicity study available; no repeated dose dermal toxicity study available.
- AF for dose response relationship:
- 1
- Justification:
- Different doses were tested in the various studies, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1.4
- Justification:
- The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- ECHA default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- No toxicodynamic differences between species; see justification attached.
- AF for intraspecies differences:
- 4
- Justification:
- Refined assessment of population differences; see justification attached.
- AF for the quality of the whole database:
- 1
- Justification:
- Results were based on key Klimisch 1-2 studies (and possible supporting studies).
- AF for remaining uncertainties:
- 2.5
- Justification:
- For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- no DNEL required: short term exposure controlled by conditions for long-term
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 17.86 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- other: ECHA factors in combination with recent scientific literature
- Overall assessment factor (AF):
- 56
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Not applicable
- AF for dose response relationship:
- 1
- Justification:
- Different doses were tested in the various studies, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1.4
- Justification:
- The factor for duration is based on subchronic, as 90-day toxicity data are available and will become updated with new studies. See justification attached.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- ECHA default allometric scaling factor for the differences between rats and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- No toxicodynamic differences between species; see justification attached.
- AF for intraspecies differences:
- 4
- Justification:
- Refined assessment of population differences; see justification attached.
- AF for the quality of the whole database:
- 1
- Justification:
- Results were based on key Klimisch 1-2 studies (and possible supporting studies).
- AF for remaining uncertainties:
- 2.5
- Justification:
- For remaining uncertainties that would result from the above assessment factors.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
- Humans do not have non-glandular stomach (forestomach).
- Gastric lesions only seen at 1 site in these animals, no other tissues are involved.
- There was a clear dose-response: it was observed at the highest and mid dose and not at the low dose, so there is a clear threshold.
- This high oral exposure volume is not applicable in humans; and humans do not have the same stomach anatomy (no forestomach in humans).
- Genotoxicity studies are negative (Ames, Micronucleus, Mammalian genotoxicity).
- It was only observed with gavage dosing; the gavage is giving a bolus dose, which is considered excessive.
Source information for DNELS:
The following source information was taken into account for DNEL calculation:
Subacute toxicity was tested with the registered substance in Wistar rats by oral gavage at 0 (propylene glycol), 100, 300 and 1000 mg /kg bw/day in a supporting 14-day dose range finding and at 0 (propylene glycol), 100, 300 and 1000 mg /kg bw/day in a key combined repeated dose/reproductive toxicity study (OECD No. 422). In summary, the test substance did not result in test item related mortality or adverse clinical signs. Test item related adverse effects were observed on body weight gain parameters and food consumption in High dose (600 mg/kg bw/day) males and moderate effects were observed on body weight and body weight gain in the gestation and lactation period for High dose females. It is most likely these effects were related to local gastric irritation. There were no adverse changes in animal behaviour, general physical condition or in the reactions to different type of stimuli or in clinical pathology in test item treated groups when compared to control. There was no test item effect on mortality or survival of the pups. Test item-related effects were observed in the liver (increased relative organ weights in Mid and High dose males and females) associated with centrilobular hepatocellular hypertrophy in the High dose. Hepatic changes were considered to be adaptive and nonadverse. Test item related effect was observed in the organ weight of the heart (decreased absolute and relative organ weight) of the High dose males (not in females) compared to controls. However, there were no histopathological findings which indicates any adversity. Histologically, test item-related changes were observed in the stomach in High and Mid dose animals with squamous hyperplasia, hyperkeratosis and ulcer of the non-glandular gastric mucosa observed at 300 and 600 mg/kg bw/day dose level in females and at 100, 300 and 600 mg/kg bw/day dose level in males, as test item-related adverse local changes. Sporadic cases of noisy respiration in a few animals ascribed to reflux or minor exposure to test item in the region of the upper respiratory tract. Also, centrilobular hepatocellular hypertrophy was observed at 600 mg/kg bw/day dose level as a non-adverse adaptive change (associated with liver weight increase). Minimal to mild multifocal eosinophilic droplets/globules were seen in the renal tubules in the High dose males and were considered as test item-related but non-adverse. The NOAEL for local toxicity of the parental generation was <100 mg/kg bw/day (based on local gastric histological effects in Low, Mid and High dose animals). The NOAEL for systemic toxicity of the parental generation was considered to be 300 mg/kg bw/day. (based on body weight, body weight gain and food consumption changes at 600 mg/kg bw/day, although these effects were probably secondary to local gastric irritation).
No test item related changes were noted in the reproductive parameters during mating and gestation, delivery and post-partum/lactation period until PPD 14. The litter size of control and treated groups were comparable. A slightly lower pup growth/weight at the High dose, while within the historic control range, may be related to maternal toxicity (gastric irritation/food intake); there is no indication of a direct adverse effect of the test item on pup development. Under the experimental conditions of this study and based on the results of thyroid hormone measurement, thyroid weights, nipple retention, anogenital distance and external reproductive organs analysis, histopathology and reproductive performance, there was no evidence for any endocrine effects. There was no test item effect on mortality or survival of the pups. The litter size of control and treated groups were comparable. A slightly lower pup growth/weight at the High dose, while within the historic control range, may be related to maternal toxicity (gastric irritation/food intake); there is no indication of a direct adverse effect of the test item on pup development. The NOAEL for reproductive effects of the parental generation was considered to be 600 mg/kg bw/day. The NOAEL for Pup development and survival was considered to be 600 mg/kg bw/day.
Repeated dose toxicity was further tested in various species, including rats, dogs, rabbits and monkeys. The NOAEL of 750 mg/kg bw/day obtained in the subchronic 90-day dietary toxicity study in rats with registered substance was confirmed to be consistent with data from category members in rats and the NOAEL of 1000 mg/kg bw of Docusate sodium in a 90-day dietary toxicity study. Other data from other species were tested with read-across substance and were of limited reliability and relevance and therefore not taken into account.
Based on the above information, the NOAEL of 300 mg/kg bw/day of the OECD 422 study is considered to be too conservative. The gross and histological changes in the non-glandular stomach (forestomach) are considered to be due to repeated irritation, and not relevant for humans, as supported by following arguments. .
In conclusion, the NOAEL of 300 mg/kg bw is rather a local NOAEL for rodents under the oral gavage conditions. As there is a NOAEL of 750-1000 mg/kg bw from the 90-day dietary toxicity study, tDNEL derivation will not be based on the oral gavage study but on the dietary 90-day study with Docusate, waiting new data from the 90-day study with registered substance. A justification for calculation of DNELs is attached.
Only systemic long term exposure values for worker and general population were calculated, because no concrete values (like NOAEL, LOAEL etc) are available from acute or irritation studies. The study design of the test conducted assessing the acute and local toxicity does not allow in general the derivation of local or acute DNEL, as most of the tests were, for example, conducted as limit tests due to animal welfare. Therefore a qualitative risk assessment for irritation is performed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.